Abstract
Primitive neuroectodermal tumors (PNETs) are composed of immature neuronal precursor cells and sometimes more mature neuronal cell types. Medulloblastomas, occuring in the cerebellum, represent the most common PNET and are broadly classified into two subgroups: classical and desmoplastic. Desmoplastic medulloblastomas exhibit a slightly better prognosis than classical medulloblastomas. However, there are currently no good molecular markers available to distinguish clinical outcome and similar treatment is used for most patients with associated complications. It has been shown that neoplastic cells in these tumors recapitulate stages in maturation of normal human neuroblasts; therefore, embryological studies of the earliest events in the development of the cerebellum may provide useful information about the molecular behavior of the tumor. Transcription factors such as Sox proteins involved in neural development may also play a role in the etiology of brain tumors. Sox4 in particular has been implicated in the biology of several other types of cancer. We have studied the expression of Sox4, and the closely related Sox11 gene, in medulloblastomas. Sox4 and Sox11 were strongly expressed in most classical medulloblastomas but only weakly in desmoplastic medulloblastomas. The expression profile of these two genes in developing cerebellum was also analyzed. Our results suggest that strong Sox4 and Sox11 expression in classical medulloblastomas reflects their maturation-dependent expression during normal cerebellum development, and that they may therefore provide markers to divide tumors into clinically relevant subgroups.
Similar content being viewed by others
References
Hart MN, Earle KM: Primitive neuroectodermal tumors of the brain in children. Cancer 32: 890-897, 1973
Yachnis AT, Rorke LB, Trojanowski JQ: Cerebellar dysplasias in humans: development and possible relationship to glial and primitive neuroectodermal tumors of the cerebellar vermis. J Neuropathol Exp Neurol 53: 61-71, 1994
Russell DS, Rubenstein LJ: Pathology of Tumors of the Nervous System. 5th edn. Williams and Wilkins, Baltimore, 1989, pp 251-279
Gilbertson RJ, Clifford SC, MacMeekin W, Wright C, Perry RH, Kelly P, Pearson ADJ, Lunec J: Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma. Cancer Res 58: 3932-3941, 1998
Buhren J, Christoph AH, Buslei R, Albrecht S, Wiestler OD, Pietsch T: Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer. J Neuropathol Exp Neurol 59: 229-240, 2000
Provias JP, Becker LE: Cellular and molecular pathology of medulloblastoma. J Neuro-Oncol 29: 35-43, 1996
Rubinstein LJ, Northfield DWC: The medulloblastoma and the so called 'arachnoidal cerebellar sarcoma'. Brain 87: 379-412, 1964
Katsetos CD, Burger PC: Medulloblastoma. Semin Diagn Pathol 11: 85-97, 1994
Scotting P, Thompson S, Punt J, Walker D: Paediatric brain tumours: an embryological perspective. Child's Nerv Syst 16: 261-268, 2000
Lee C, Appleby V, Orme A, Punt J, Walker D, Scotting P: Transcription factors expressed during normal neurogenesis also exhibit widespread and varied expression in primitive neuroectodermal tumours. Neuro-Oncol 2: S19, 2000
Rostomily R, Bermingham-McDonough O, Berger M, Tapscott S, Reh T, Olson J: Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors. Cancer Res 57: 3526-3531, 1997
Bodey B, Bodey B Jr, Siegel SE, Kaiser HE: Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhood medulloblastomas/primitive neuroectodermal tumors. Anticancer Res 20: 1769-1780, 2000
Yokota N, Aruga J, Takai S, Yamada K, Hamazaki M, IwaseT, Sugimura H, Mikoshiba K: Predominant expression of human zic in cerebellar granule cell lineage and medulloblastoma. Cancer Res 56: 377-283, 1996
McGowan EM, Clarke CL: Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells. Mol Endocrinol 13: 1657-1671, 1999
Ahn SG, Cho GH, Jeong SY, Rhim H, Choi JY, Kim IK: Identification of cDNAs for Sox-4, an HMG-Box protein, and a novel human homolog of yeast splicing factor SSF-1 differentially regulated during apoptosis induced by prostaglandin A2/delta12-PGJ2 in Hep3B cells. Biochem Biophys Res Commun 260: 216-221, 1999
McCracken S, Kim CS, Xu Y, Minden M, Miyamoto NG: An alternative pathway for expression of p56lck from type I promoter transcripts in colon carcinoma. Oncogene 15: 2929-2937, 1997
Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, Foster JW, Frischauf AM, Lovell-Badge R, Goodfellow PN: A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346: 240-244, 1990
Harley VR, Lovell-Badge R, Goodfellow PN: Definition of a consensus DNA binding site for SRY. Nucleic Acids Res 22: 1500-1501, 1994
Wegner M: From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res 27: 1409-1420, 1999
Kamachi Y, Uchikawa M, Kondoh H: Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet 4: 182-187, 2000
Rex M, Orme A, Uwanogho D, Tointon K, Wigmore PM, Sharpe PT, Scotting PJ: Dynamic expression of chicken Sox2 and Sox3 genes in ectoderm induced to form neural tissue. Dev Dyn 209: 323-332, 1997
Collignon J, Sockanathan S, Hacker A, Cohentannoudji M, Norris D, Rastan S, Stevanovic M, Goodfellow PN, Lovell-Badge R: A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. Development 122: 509-520, 1996
Hargrave M, Wright E, Kun J, Emery J, Cooper L, Koopman P: Expression of the Sox11 gene in mouse embryos suggests roles in neuronal maturation and epithelio-mesenchymal induction. Dev Dyn 210: 79-86, 1997
Jay P, Goze C, Marsollier C, Taviaux S, Hardelin J-P, Berta P: The human Sox11 gene: cloning, chromosomal assignment and tissue expression. Genomics 29: 541-545, 1995
Pusch C, Hustert E, Pfeifer D, Südbeck P, Kist R, Roe B, Wang Z, Balling R, Blin N, Scherer G: The SOX10/Sox10 gene from human and mouse: sequence, expression and transactivation by the encoded HMG domain transcription factor. Hum Genet 103: 115-123, 1998
Tani M, Shindo-Okada N, Hashimoto Y, Shiroishi T, Takenoshita S, Nagamachi Y, Yokota J: Isolation of a novel Sry-related gene that is expressed in high-metastatic K-1735 murine melanoma cells. Genomics 39: 30-37, 1997
Xia Y, Papalopulu N, Vogt PK, Li J: The oncogenic potential of the high mobility group box protein Sox3. Cancer Res 60: 6303-6306, 2000
Cheung M, Abu-Elmagd M, Clevers H, Scotting PJ: Roles of Sox4 in central nervous system development. Brain Res Mol Brain Res 79: 180-191, 2000
Zorn AM, Barish GD, Williams BO, Lavender P, Klymkowsky MW, Varmus HE: Regulation of Wnt signaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin. Mol Cell 4: 487-498, 1999
Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumors of the Central Nervous System. Springer, New York, 1993
Jones TA, Flomen RH, Senger G, Nizetic D, Sheer D: The homeobox MEIS1 is amplified in IMR-32 and highly expressed in other neuroblastoma cell lines. Eur J Cancer 36: 2368-2374, 2000
Rex M, Church R, Tointon K, Scotting PJ: Combination of nonisotopic in situ hybridization with detection of enzyme activity, bromodeoxyuridine incorporation and immunohistochemical markers. Histochem Cell Biol 107: 519-523, 1997
Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL: Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 91: 12867-12871, 1994
Friedman HS, Burger PC, Bigner SH, Trojanowski JQ, Wikstrand CJ, Halperin EC, Bigner DD: Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med. J Neuropathol Exp Neurol 44: 592-605, 1985
U HS, Banaie A, Rigby L, Chen J: Mutant p53 may selectively suppress glial specific proteins in pluripotential human neuroectodermal tumor cells. Neurosci Lett 244: 41-46, 1998
Mork SJ, May EE, Papasozomenos SC, Vinores SA: Characteristics of human medulloblastoma cell line TE-671 under different growth conditions in vitro: a morphological and immunohistochemical study. Neuropathol Appl Neurobiol 12: 277-289, 1986
Katsetos CD, Liu HM, Zacks SI: Immunohistochemical and ultrastructural observations on Homer Wright (neuroblastic) rosettes and the 'pale islands' of human cerebellar medulloblastomas. Hum Pathol 10: 1219-1227, 1988
Katsetos CD, Herman MM, Frankfurter A, Gass P, Collins VP, Walker CC, Rosemberg S, Barnard RO, Rubinstein LJ: Cerebellar desmoplastic medulloblastomas. A further immunohistochemical characterization of the reticulin-free pale islands. Arch Pathol Lab Med 113: 1019-1029, 1989
Eastman Q, Grosschedl R: Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 11: 233-240, 1999
Huang H, Mahler-Araujo BM, Sankila A, Chimelli L, Yonekawa Y, Kleihues P, Ohgaki H: APC mutations in sporadic medulloblastomas. Am J Pathol 156: 433-437, 2000
Kozmik Z, Sure U, Ruedi D, Busslinger M, Aguzzi A: Deregulated expression of PAX5 in medulloblastoma. Proc Natl Acad Sci USA 92: 5709-5713, 1995
Rasheed BK, Bigner SH: Genetic alterations in glioma and medulloblastoma. Cancer Metastasis Rev 10: 289-299, 1991
Iijima M, Nakazato Y: Pale islands in medulloblastoma consist of differentiated cells with low growth potential. Pathol Int 47: 25-30, 1997
Hooper WC, Zaki SR, Pruckler J, Garcia J, Evatt BL: Phorbol ester induces morphological changes and acidic fibroblast growth factor RNA expression in the RD/TE 671 cell line. Pathobiology 58: 198-203, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, CJ., Appleby, V.J., Orme, A.T. et al. Differential Expression of SOX4 and SOX11 in Medulloblastoma. J Neurooncol 57, 201–214 (2002). https://doi.org/10.1023/A:1015773818302
Issue Date:
DOI: https://doi.org/10.1023/A:1015773818302